Specialization Tags
Biography
As engineering capacity becomes less constraining, choosing the right problems to focus on become business-defining decisions. Aaron Del Duca helps founders figure out what’s worth building, who will pay for it, and how to turn a promising technology into a growing business. Aaron brings more than 20 years of experience across life sciences, medical devices, diagnostics, and software. He joined DNA Genotek (now OraSure) as employee #9, rose to VP Product, and later built its microbiome business from idea to 10s of millions in revenue across 40 countries, acquiring and integrating two companies along the way. His experience also includes executive leadership roles at DayTwo (now Danone), Karius, Invitae (now LabCorp), One Codex, and serving as interim CEO of CryoStasis (a Genesys Capital company). As Principal at OMX Advisors, he supports builders with tools for understanding customers: what they’re trying to accomplish, where existing solutions fall short, and what would make switching worthwhile. As an advisor or fractional executive, he helps turns those insights into actionable strategies for business model validation, product development, partnerships, organizational design, and M&A.
What Companies and What Challenges?
- Life Sciences startups with several possible applications that need to decide which customer, problem, and market to pursue first. - Diagnostics, medical device, and health-tech companies translating complex technology into a compelling reason to buy. - Technical founders validating a business concept who need to test demand, challenge assumptions, and establish what customers would pay for. - Life Sciences and health-tech companies with promising pilots but limited commercial traction that need to understand what will move customers from interest to adoption. - Early-stage leadership teams preparing to raise capital that need to connect customer evidence, product priorities, and commercial milestones into a credible investor narrative.
Network
- Product and business leads across life sciences tools and technology companies, with a concentration in omics, diagnostics, biopreservation, regenerative medicine. - Biopharma and lab testing partners who could support tech evaluation, co-development, or potential partnerships. - Experienced startup operators with domain expertise in regulatory affairs, quality management, bioinformatics, software development, machine learning, assay design, molecular diagnostics, biomarker discovery, sales & marketing. - Channel partners & distributors for select life sciences tools & tech.